MassMutual Private Wealth & Trust’s Mirum Pharmaceuticals MIRM Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.7K	Buy	91 +1	+1%	+$100	﹤0.01%	1383
2026 Q1	$8.31K	Buy	90 +9	+11%	+$847	﹤0.01%	1435
2025 Q4	$6.4K	Sell	81 -1	-1%	-$72	﹤0.01%	1576
2025 Q3	$6.01K	Buy	82 +1	+1%	+$64	﹤0.01%	1597
2025 Q2	$4.12K	Buy	81 +2	+3%	+$89	﹤0.01%	1706
2025 Q1	$3.56K	Hold	79	–	–	﹤0.01%	1725
2024 Q4	$3.27K	Hold	79	–	–	﹤0.01%	1685
2024 Q3	$3.08K	Buy	79 +5	+7%	+$199	﹤0.01%	1534
2024 Q2	$2.53K	Buy	+74	New	+$1.94K	﹤0.01%	1556

Other funds holding MIRM

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Highlander Partners Dallas, Texas $298M AUM 53.88% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

MassMutual Private Wealth & Trust's MIRM Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Mirum Pharmaceuticals (MIRM) stake by 1.1% in Q2 2026, buying an estimated $100 and bringing the position to 91 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1383.

MassMutual Private Wealth & Trust first reported a position in MIRM in Q2 2024 and has held it in 9 quarters since. 77 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

MassMutual Private Wealth & Trust held 91 shares of Mirum Pharmaceuticals worth $10.7K as of Q2 2026.
MassMutual Private Wealth & Trust bought 1 Mirum Pharmaceuticals share in Q2 2026, an estimated $100.
Mirum Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1383 holding.
MassMutual Private Wealth & Trust first reported a position in Mirum Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
77 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.